2017 End-of-Year Xarelto Lawsuit News That You NEED to Know About!
It has been a long year for those harmed by the blood thinner Xarelto. Over 20,000 lawsuits against Xarelto manufacturers are still pending in court with the pharmaceutical giant winning the first three cases that have gone into litigation.
However, one Indiana family has won the first case against Xarelto, shining a light at the end of a very dark and long tunnel. Aside from the ongoing Xarelto lawsuit, recent research funded by the makers of the drug found unexpected results – and was shockingly – abandoned.
At Hotze Runkle, our Texas attorneys keep up-to-date with the latest news about Xarelto proceedings to not only keep ourselves informed but, most importantly, our clients and readers informed as well. More and more people are waking up and realizing that their trust has been broken by the pharmaceutical makers of Xarelto. If you have been affected by the drug, you are not alone. Let our experienced Xarelto litigation lawyers earn your trust.The percentage of #Xarelto lawsuits has grown by 27% this past year. #HotzeRunkle Click To Tweet
The First Case Won Concerning the Drug Xarelto
Lynn Hartman had been taking Xarelto for over a year when she was hospitalized for intestinal bleeding in 2014. It took four blood transfusions to counteract the life-threatening bleed-out effect of the drug. Because of this, Lynn rightfully filed a lawsuit against the makers of Xarelto in 2015.
On December 5, 2017, Bayer AG and Johnson & Johnson, who jointly developed Xarelto, were ordered by a Philadelphia jury to pay out over $26 million in punitive and $1.8 million in compensatory damages to an Indiana couple who claimed they were not provided sufficient warnings about the risks of internal bleeding caused by the anticoagulant.
It was the first case won in Philadelphia, with over 1,400 more cases pending there. Over 18,500 more cases are still pending within the multidistrict litigation at the U.S. District Court for the Eastern District of Louisiana, and that number grows daily.
Win Sets Precedent
Before this win, juries had ruled that the pharmaceutical companies had indeed issued proper warnings and that the drug was safe. This win signifies hope that those harmed by Xarelto’s dangerous effects can receive restitution for their suffering.
Aside from the major headway being made regarding Xarelto lawsuits, studies are showing that Xarelto may not be as effective as once believed.
Makers of Xarelto Abandon a Clinical Study Concerning One of Its Main Purposes
A governmental study was recently abandoned by Bayer and Johnson & Johnson because there was “no efficacy improvement over aspirin at an interim analysis and very little chance of showing overall benefit if the study were completed.”
In other words, the study was abandoned when researchers found that using Xarelto doesn’t provide much more of a benefit over low-dose aspirin at preventing secondary strokes following strokes caused by blood clots or other unknown origins.
This is a monumental find but not the nail in the coffin for Xarelto. The makers of the drug are running another study and are hopeful that the effects will be more beneficial than aspirin.#StatuteOfLimitations in #Texas for product liability = 2 years #HotzeRunkle #Xarelto Click To Tweet
Now is the time to take a stand against Xarelto if you or someone you love has been harmed. Let Hotze Runkle represent you!
As a friendly reminder to all those that have been impacted by the harmful anticoagulant, Xarelto, contact our litigation team at (512) 476-7771 or (877) 919-0830 today as the statute of limitations for product liability in the state of Texas is two years from the date of the event.
There may still be time to make things right. Let us fight for you. Call today.